Corporate Program

GHIT Fund: Unlocking the Secret of Global Health Victories

The Global Health Innovative Technology Fund (GHIT Fund) is aimed at promoting the discovery and development of new pharmaceutical drugs, vaccines and diagnostics for infectious disease prevalent in developing countries. The first public-private partnership of its kind in Japan, the GHIT Fund was established by the government of Japan, a consortium of Japanese pharmaceutical companies and the Bill & Melinda Gates Foundation. In this program, our panelists will discuss recent successes and setbacks in global health, as well as what they regard as necessary to bring new vaccines and cures into the field. The panelists will also provide their perspectives concerning how to make public-private partnerships succeed, what lessons to take from past successes, and where the next big opportunities in global health are.

BT Slingsby
, CEO & Executive Director, GHIT Fund

Kiyoshi Kurokawa
, Chair of the Board & Representative Director, GHIT Fund
Peter Piot, Director, London School of Hygiene & Tropical Medicine
Melvin Spigelman, President & Chief Executive Officer, Global Alliance for TB Drug Development
Ann Veneman, Former Executive Director, UNICEF

Ko-Yung Tung,
Senior Partner, Morrison & Foerster LLP

Sponsored by the Global Health Innovative Technology Fund.

Co-presented by the New York Academy of Sciences.

You will need Adobe Flash Player to view the webcasts, please click here to download Adobe Flash Player.

Calendar of Events

February 2018

S M T W Th F S
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28      
All content © 2018, Japan Society, unless otherwise noted. |
333 East 47th Street New York, NY 10017 Phone: 212.832.1155 |
Credits | Press | Contact Us | Privacy Policy